EUVIMEDEUVIMED entdecken
Crossref

A Buyer's Guide to Generic Pharmaceutical Acquisitions

Stephen D. Sayre

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector · 2008

DOI: 10.1057/jgm.2008.28 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 2008. Verfasst von Stephen D. Sayre.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper provides the generic pharmaceutical executive with a legal roadmap for acquiring pharmaceutical assets. It describes the three main steps to product acquisition, which are as follows: (1) negotiation and execution of a detailed letter of intent; (2) performance of buyer's due diligence; and (3) negotiation and closing of the acquisition agreement. It also explains the relationship among these three steps and why each step is important to the buyer. In discussing each step of the acquisition process, this paper identifies the key considerations and issues for the buyer to help the buyer mitigate the risks inherent in the acquisition of generic pharmaceutical assets.

Zitieren

APA

Sayre, S. D. (2008). A Buyer's Guide to Generic Pharmaceutical Acquisitions. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. https://doi.org/10.1057/jgm.2008.28

Vancouver

Sayre SD. A Buyer's Guide to Generic Pharmaceutical Acquisitions. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 2008. doi:10.1057/jgm.2008.28

BibTeX
@article{Sayre2008,
  author = {Sayre, Stephen D.},
  title = {A Buyer's Guide to Generic Pharmaceutical Acquisitions},
  journal = {Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector},
  year = {2008},
  doi = {10.1057/jgm.2008.28}
}
Kostenlos starten →